These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 32685557)
41. Effects of ADIPOQ polymorphisms on individual susceptibility to coronary artery disease: a meta-analysis. Wang Z; Diao J; Yue X; Zhong J Adipocyte; 2019 Dec; 8(1):137-143. PubMed ID: 30879388 [TBL] [Abstract][Full Text] [Related]
42. An association study of SNP + 45 T > G of the AdipoQ gene with type 2 diabetes in Yi and Han people in China. Wang B; Wang C; Wei D; Zhang J; He H; Ma M; Li X; Pan L; Xue F; Jonasson JM; Shan G Int J Vitam Nutr Res; 2011 Nov; 81(6):392-7. PubMed ID: 22673923 [TBL] [Abstract][Full Text] [Related]
43. Associations between angiotensinogen M235T polymorphisms and the risk of diabetic nephropathy: A meta-analysis. Zhou B; Wen M; Mi L; Hu CJ; Zhang Y; Wang JT; Tang L Diabetes Res Clin Pract; 2018 Aug; 142():26-36. PubMed ID: 29775675 [TBL] [Abstract][Full Text] [Related]
44. ADIPOQ gene polymorphisms and cancer risk: a meta-analysis. Yang Y; Zhang F; Ding R; Skrip L; Wang Y; Lei H; Hu D Cytokine; 2013 Feb; 61(2):565-71. PubMed ID: 23200411 [TBL] [Abstract][Full Text] [Related]
45. Correlation of the TCF7L2 (rs7903146) polymorphism with an enhanced risk of type 2 diabetes mellitus: a meta-analysis. Guan Y; Yan LH; Liu XY; Zhu XY; Wang SZ; Chen LM Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706609 [TBL] [Abstract][Full Text] [Related]
46. Association Between MTHFR C677T Polymorphism and Congenital Heart Disease. Liu PF; Ding B; Zhang JY; Mei XF; Li F; Wu P; Mei CH; Zhou YF; Chen T Int Heart J; 2020 May; 61(3):553-561. PubMed ID: 32418960 [TBL] [Abstract][Full Text] [Related]
47. Interleukin-6 gene -174G>C promoter polymorphism reduces the risk of periodontitis in Brazilian populations: A meta-analysis. Mehar R; Swarnakar S; Lakkakula S; Verma HK; Bhaskar LVKS J Oral Biosci; 2021 Dec; 63(4):388-393. PubMed ID: 34478874 [TBL] [Abstract][Full Text] [Related]
48. Associations of the Polymorphisms in ADIPOQ with Circulating Levels of Adiponectin and Lipids: A Meta-Analysis. Su M; Jia A; He Y; Song Y Horm Metab Res; 2021 Aug; 53(8):541-561. PubMed ID: 34384110 [TBL] [Abstract][Full Text] [Related]
49. A Systematic Narrative Review on Khan MD; Srivastava RK; Upadhyay TK; Khan MM Endocr Metab Immune Disord Drug Targets; 2024; 24(10):1161-1168. PubMed ID: 38333969 [TBL] [Abstract][Full Text] [Related]
50. Association between X-ray repair cross-complementing group 1(XRCC1) Arg399Gln polymorphism and endometriosis: A systematic review and meta-analysis. Lv MQ; Wang J; Yu XQ; Hong HH; Ren WJ; Ge P; Zhou DX Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():12-20. PubMed ID: 28926725 [TBL] [Abstract][Full Text] [Related]
51. CAV1 polymorphisms rs1049334, rs1049337, rs7804372 might be the potential risk in tumorigenicity of urinary cancer: A systematic review and meta-analysis. Fan S; Meng J; Zhang L; Zhang X; Liang C Pathol Res Pract; 2019 Jan; 215(1):151-158. PubMed ID: 30463805 [TBL] [Abstract][Full Text] [Related]
52. The possible association between the presence of an MPO -463 G > A (rs2333227) polymorphism and cervical cancer risk. Shi X; Li B; Yuan Y; Chen L; Zhang Y; Yang M; Wang J; Qin D Pathol Res Pract; 2018 Aug; 214(8):1142-1148. PubMed ID: 29937309 [TBL] [Abstract][Full Text] [Related]
53. Gene Polymorphisms of ADIPOQ +45T>G, UCP2 -866G>A, and FABP2 Ala54Thr on the Risk of Colorectal Cancer: A Matched Case-Control Study. Hu X; Yuan P; Yan J; Feng F; Li X; Liu W; Yang Y PLoS One; 2013; 8(6):e67275. PubMed ID: 23826253 [TBL] [Abstract][Full Text] [Related]
54. A Meta-analysis of ADIPOQ rs2241766 polymorphism association with type 2 diabetes. Hamidi Y; Saki S; Afraz ES; Pashapour S J Diabetes Metab Disord; 2022 Dec; 21(2):1895-1901. PubMed ID: 36404807 [TBL] [Abstract][Full Text] [Related]
55. Association of adiponectin (ADIPOQ) rs2241766 polymorphism and dyslipidemia in HIV/HCV-coinfected patients. Pineda-Tenor D; Berenguer J; García-Broncano P; Jiménez-Sousa MA; Fernández-Rodríguez A; Diez C; García-Álvarez M; Carrero A; Catalán P; Aldámiz-Echevarria T; Resino S Eur J Clin Invest; 2014 May; 44(5):453-62. PubMed ID: 24528335 [TBL] [Abstract][Full Text] [Related]
56. The CEBPE rs2239633 genetic polymorphism on susceptibility to childhood acute lymphoblastic leukemia: an updated meta-analysis. Liu J; Weiling G; Xueqin L; Liang X; Linhong W; Zhongwen C Environ Health Prev Med; 2021 Jan; 26(1):2. PubMed ID: 33397280 [TBL] [Abstract][Full Text] [Related]
57. Association between AGTR1 A1166C polymorphism and the susceptibility to diabetic nephropathy: Evidence from a meta-analysis. Zhuang Y; Niu F; Liu D; Sun J; Zhang X; Zhang J; Guo S Medicine (Baltimore); 2018 Oct; 97(41):e07689. PubMed ID: 30313019 [TBL] [Abstract][Full Text] [Related]
58. The updated relationship between the cleft‑lip and palate transmembrane protein‑1‑like rs401681 and lung cancer risk: A systematic review and meta‑analysis. Fang Z; Zhao G; Wang Y; Li F; Ding Z Mol Clin Oncol; 2024 Oct; 21(4):70. PubMed ID: 39113849 [TBL] [Abstract][Full Text] [Related]
59. Chronic Kidney Disease: Interaction of Adiponectin Gene Polymorphisms and Diabetes. Chen HH; Huang YL; Chen MC; Wu CY; Lin YC; Shiue HS; Hsu SL; Hsueh YM Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175838 [TBL] [Abstract][Full Text] [Related]
60. Association of KALRN, ADIPOQ, and FTO gene polymorphism in type 2 diabetic patients with coronary artery disease: possible predisposing markers. Mofarrah M; Ziaee S; Pilehvar-Soltanahmadi Y; Zarghami F; Boroumand M; Zarghami N Coron Artery Dis; 2016 Sep; 27(6):490-6. PubMed ID: 27218147 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]